Unlock instant, AI-driven research and patent intelligence for your innovation.

Adriablastina antineoplastic medicine and gland correlated virus composite preparations and uses thereof

A technology of anti-tumor drugs and compound preparations, applied in the field of biomedicine, can solve the problems of low expression level of therapeutic genes, low cell infection and transduction efficiency, etc., and achieve the effects of increasing positive rate, improving curative effect, and increasing expression level

Inactive Publication Date: 2008-02-06
SHANGHAI FIRST PEOPLES HOSPITAL
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] However, AAV vectors also have certain limitations: ①After AAV virus infection, it takes a long time for the foreign gene it carries to express, this is because AAV is a single-stranded DNA virus, which must be transformed into a double-stranded DNA virus after entering the cell. It begins to express, so it is not suitable for diseases that require rapid effects of therapeutic genes; ②The infection and transduction efficiency of cells is low, usually 1×10 lower than that of adenovirus 3 ~1×10 4 times
③In general, the expression level of therapeutic genes is low
[0010] So far, there have been no reports of doxorubicin improving AAV-mediated gene transduction efficiency and expression levels, and attempts to use doxorubicin to enhance AAV-mediated transduction in gene therapy, especially for degenerative and genetic diseases Reporting of efficiency and gene expression levels

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Adriablastina antineoplastic medicine and gland correlated virus composite preparations and uses thereof
  • Adriablastina antineoplastic medicine and gland correlated virus composite preparations and uses thereof
  • Adriablastina antineoplastic medicine and gland correlated virus composite preparations and uses thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0079] Example 1 Adriamycin Accelerates and Improves the Transduction Efficiency and Gene Expression Level of Retinal Cells by rAAV-GFP

[0080] According to the time of adding doxorubicin, the experiment was divided into three groups: the first group was incubated with doxorubicin in advance, and rAAV was added after 24 hours 2 -GFP; the second group added doxorubicin and rAAV at the same time 2 -GFP; the third group added rAAV first 2 - For GFP infection, doxorubicin was added 24 hours later.

[0081] 2×10 per hole 5 RPE (APRE-19, ATCC) cells were seeded in 6-well cell culture plates, and after 24 hours, the cells adhered to the wall, and 1×10 9 wxya 2 -GFP with a final concentration of 0.001μg / ml (0.001μg), 0.01μg / ml (0.01μg), 0.05μg / ml (0.05μg), 0.1μg / ml (0.1μg), 1.3μg / ml (1.3μg) , 1.7 μg / ml (1.7 μg), 2.6 μg / ml (2.6 μg) doxorubicin were added to the cultured cells simultaneously or first or later. Then observe and record the brightness of GFP fluorescence, cell morp...

Embodiment 2

[0086] Example 2 Adriamycin Accelerates and Improves the Transduction Efficiency and Gene Expression Level of Retinal Cells by rAAV-Luc

[0087] 1×10 per well 5 RPE (APRE-19, ATCC) cells were seeded in 24-well cell culture plates, and after 24 hours, the cells adhered to the wall, and 1×10 6 , 1×10 7 , 1×10 8 or 1×10 9 wxya 2 -Luc alone or in combination with 0.1 μg / ml (0.1 μg) doxorubicin was added to the cultured cells at the same time. On the 3rd day after infection, after trypsinization, the cells were collected and lysed, and the corresponding substrate was added to the lysate. Detect the intensity of fluorescence in the cell lysate to analyze and compare rAAV under different conditions 2 - Transduction efficiency of RPE cells by Luc. The results are as follows: Adeno-associated virus was applied alone from 1×10 6 to 1×10 9 The intracellular Luc fluorescence intensity values ​​(RIU) were 131, 136, 613 and 3556, respectively. for 3211, 16237, 209866 and 1637928. ...

Embodiment 3

[0088]Example 3 Doxorubicin accelerated and improved the transduction efficiency and gene expression level of rAAV-GFP and rAAV-Luc to living retinal cells, improving the therapeutic effect.

[0089] A Doxorubicin increases the expression level of AAV-mediated genes in living retinal cells

[0090] Select 10 8-week-old SD rats (one died after anesthesia), male or female, and randomly divide them into 3 groups. Group 1: Combined injection of rAAV2-GFP and doxorubicin (2.5ul) into the subretinal space of the right eye , the dosage of rAAV2-GFP was 1×10 9 For virus particles, the concentration of doxorubicin was 0.1 μg / ml (0.1 μg) and 1.3 μg / ml (1.3 μg); the left eye was the control eye, and rAAV2-GFP was injected separately in the subretinal space, 1×10 9 Virus particles (2.5ul). The second group: Adriamycin (2ul) was injected into the vitreous cavity of the right eye at a concentration of 0.1 μg / ml (0.1 μg) and 1.3 μg / ml (1.3 μg), and rAAV2-GFP was injected into the subretina...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the biologic medicine filed and relates to a novel gene therapy compound preparation and the use and application method thereof. When adeno-associated virus is used as gene delivery carrier, a certain dose of adriamycin is combined in use, and obviously advances expression time of foreign gene mediated by adeno-associated virus, obviously increases the transfer efficiency and gene expression level, and prolongs expression time. The experiment result indicates that the compound preparation does not have obvious toxic and side effects on cells. The compound preparation and application method thereof can be used in instructing and assisting gene therapy for ophthalmopathy, genetic disease and tumor.

Description

technical field [0001] The invention belongs to the field of biomedicine and relates to a new compound preparation for gene therapy, in particular to a compound preparation of doxorubicin antitumor drugs and adeno-associated virus and its application and application method. Background technique [0002] Adeno-associated virus (adeno-associated virus, AAV) belongs to parvoviridae, at least 8 serotypes of AAV, AAV1-AAV8, have been found. Their main difference lies in the capsid protein, and thus lead to different infection efficiencies of various serotypes of AAV to different tissues and cells. Currently, the AAV commonly used in the field of gene therapy is serotype 2, namely AAV2. The recombinant adeno-associated virus produced by genetic engineering is called rAAV. The advantages of rAAV as a gene delivery carrier mainly include: ① AAV is non-pathogenic to humans and is very safe. AAV shell protein can be detected in the serum of about 80% of adults ② low immunogenicity, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K48/00A61K39/235A61K31/7076A61K31/704A61K9/19A61K9/08A61P35/00A61P19/02A61P3/00A61P9/10A61P21/00
Inventor 黄倩吴继红张圣海吴小兵董小岩裘玮刘新建陈霞芳谢匡成李惠明李川源
Owner SHANGHAI FIRST PEOPLES HOSPITAL